Price (delayed)
$28.8
Market cap
$17.21B
P/E Ratio
16.09
Dividend/share
$0.82
EPS
$1.79
Enterprise value
$22.5B
Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.